Dosimetric optimization of therapy of metastatic differentiated thyroid cancer with124I PET: initial results of an ongoing phase II trial

被引：0
|
作者：
Chiesa, C. [1 ]
Gorgoni, G. [2 ]
Rubino, F. [1 ]
Olivari, L. [2 ]
Mazzaglia, S. [1 ]
Severi, F. [2 ]
Bagnalasta, M. [1 ]
Kirienko, M. [1 ]
Fuoco, V. [1 ]
Alessi, A. [1 ]
Lorenzoni, A. [1 ]
Borrello, M. [1 ]
Brusa, A. [1 ]
Rodari, M. [3 ]
Rubino, M. [4 ]
Massri, K. [5 ]
Zerbini, F. [6 ]
Muni, A. [7 ]
Pomposelli, E. [7 ]
Maggiore, R. [8 ]
Chiti, A. [8 ,9 ]
Grappeja, L. [10 ]
Seregni, E. [1 ]
Salgarello, M. [2 ]
Maccauro, M. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] IRCCS Sacro Cuore Don Calabria, Negrar, Italy
[3] Humanitas Clin Inst, Rozzano, Italy
[4] European Inst Oncol, Milan, Italy
[5] Legnano Gen Hosp, Legnano, Italy
[6] Policlin Monza, Monza, Italy
[7] Azienda Osped Nazl SS Antonio & Biagio & Cesare A, Alessandria, Italy
[8] IRCCS Osped San Raffaele, Milan, Italy
[9] Univ Vita Salute San Raffaele, Fac Med & Surg, Milan, Italy
[10] Univ Milan, Specializat Sch Nucl Med, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0945
引用
收藏
页码：S810 / S810
页数：1
相关论文
共 50 条
  • [21] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
  • [22] Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results.
    Gramza, A. W.
    Wells, S. A.
    Balasubramaniam, S.
    Fojo, A. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer
    Klopper, Joshua
    Kane, Madeleine
    Jimeno, Antonio
    Sams, Sharon
    French, Jena
    Pike, Laura
    Tompkins, Kenneth
    Haugen, Bryan
    THYROID, 2015, 25 (05) : 563 - 564
  • [24] Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
    Kloos, Richard T.
    Ringel, Matthew D.
    Knopp, Michael V.
    Hall, Nathan C.
    King, Mark
    Stevens, Robert
    Liang, Jiachao
    Wakely, Paul E., Jr.
    Vasko, Vasyl V.
    Saji, Motoyasu
    Rittenberry, Jennifer
    Wei, Lai
    Arbogast, Daria
    Collamore, Minden
    Wright, John J.
    Grever, Michael
    Shah, Manisha H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1675 - 1684
  • [25] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer
    Plyku, Donika
    Hobbs, Robert F.
    Huang, Kevin
    Atkins, Frank
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1146 - 1154
  • [26] Thyroid Remnant Dose: 124I-PET/CT Dosimetric Comparison of rhTSH versus Thyroid Hormone Withholding Before Radioiodine Remnant Ablation in Differentiated Thyroid Cancer
    Freudenberg, L. S.
    Froemke, C.
    Petrich, T.
    Marlowe, R. J.
    Koska, W. W.
    Brandau, W.
    Eising, E. G.
    Knust, E. J.
    Bockisch, A.
    Jentzen, W.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (07) : 393 - 399
  • [27] Does the dosimetric study with 124-Iodine match the real pharmacokinetic of 131-Iodine during therapy of metastatic Differentiated Thyroid Cancer?
    Rossi, G.
    Ancidei, S.
    Barucca, S.
    Berbellini, A.
    Capoccetti, F.
    Ferretti, F.
    Manni, C.
    Nicoli, P. S.
    Palucci, A.
    Poggiu, A.
    Fattori, S.
    Brianzoni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S200 - S201
  • [28] Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with 124I
    Jakob W. Kist
    Manfred van der Vlies
    Otto S. Hoekstra
    Henri N. J. M. Greuter
    Bart de Keizer
    Marcel P. M. Stokkel
    Wouter V. Vogel
    Marc C. Huisman
    Arthur van Lingen
    EJNMMI Research, 6
  • [29] Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with 124I
    Kist, Jakob W.
    van der Vlies, Manfred
    Hoekstra, Otto S.
    Greuter, Henri N. J. M.
    de Keizer, Bart
    Stokkel, Marcel P. M.
    Vogel, Wouter V.
    Huisman, Marc C.
    van Lingen, Arthur
    EJNMMI RESEARCH, 2016, 6
  • [30] Value of 124I PET/CT in staging of patients with differentiated thyroid cancer.
    Freudenberg, LS
    Mueller, S
    Antoch, G
    Beyer, T
    Knust, J
    Goerges, R
    Jentzen, WJ
    Brandau, W
    Debatin, J
    Bockisch, A
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 280P - 281P
12345